Teva Pharmaceutical Industries Limited (TEVA) fundamentals score
Teva Pharmaceutical Industries is a biopharmaceutical company, enabled by a world-class generics business. For over 120 years, its commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, it is dedicated to addressing patients’ needs, now and in the future.
Pharmaceutical Preparations · Healthcare · Listed on NYSE
Overall: 5.4 out of 10, Mixed fundamentals
- Growth: 5.0/10
- Profitability: 6.4/10
- Financial health: 4.0/10
- Earnings quality: 8.6/10
- Valuation: 2.8/10
Scores are calculated from Teva Pharmaceutical Industries Limited’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10